Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by subaru1ion Feb 28, 2024 8:26pm
84 Views
Post# 35905307

It's what you don't see: Pfizer's thrust is in oncology BUT

It's what you don't see: Pfizer's thrust is in oncology BUTyet, they have not announced any new major cancer drugs by way of old school pharma, making synthetic drugs.    

Bourla, CEO of Pfizer said in 1 3 people globally will be affected by cancer in their life time but yet they have not announced any major new 'synthesized molecular' cancer drugs.  

I just have one question, with LABS saying they have over 20 strong clinical trials, many in late stage, then what is Bourla of Pfizer doing in the field of cancer drugs? 

It's not always what you see but what you don't see that sometimes matters most. 

Subtle, but yet very effective. 
<< Previous
Bullboard Posts
Next >>